CSR Program: Jhpiego | Takeda Pharmaceuticals

Young couple next to each other. Woman carrying a baby

Building a mother-focused and scalable maternal and newborn health system in India

Raising the quality and continuity of care and leveraging predictive analytics and innovative financing in maternal and newborn health

jhpiego logo. John Hopkins University Affiliate

The Program

Partner: Jhpiego

Budget: 890 million yen

Term: 5 years

Launch: 2021

Area: India

Visit the Jhpiego websiteGo to https://www.jhpiego.org/

India accounts for 17% of global maternal deaths and 26% of global neonatal deaths. Delays in reaching and receiving care, inadequate provider competency, poor care quality, limited data availability and fragmented systemic support contribute to adverse effects for women and newborns. The program will decentralize care to promote coordinated, patient-centered approaches for antenatal through to postnatal care; develop a digital tracking platform for pregnant women; and enable early identification of high-risk pregnancies by leveraging predictive analytics. The program aims to provide targeted care to women and encourage informed decision-making.

group of women sitting in circle

Photo Credit: Indrani Kashyap

Mother with two children

Photo Credit: Kanika Bajaj

Mother carrying newborn while speaking to physician

Photo Credit: Kate Holt

Have more questions?

Contact us if you'd like more information about our Global CSR Program.

Banner Image Credit: Indrani Kashyap